1、Xiaonan Zhang#, Yun Tan#, Yun Ling#, Gang Lu#, Feng Liu#, Zhigang Yi#,Xiaofang Jia, Min Wu, Bisheng Shi, Shuibao Xu, Jun Chen, Wei Wang, BingChen, Lu Jiang, Shuting Yu, Jing Lu, Jingzheng Wang, Mingzhu Xu, Zhenghong Yuan, Qin Zhang, Xinxin Zhang, Guoping Zhao, Shengyue Wang*, SaijuanChen*, Hongzhou Lu*.Viral and host factors related to the clinic outcome of the SARS-CoV-2 infection/'Nature. Accepted 2、Lu, Hongzhou. Drug treatment options for the 2019-new coronavirus (2019- nCoV).BiosciTrends. 14, no. 1 (2020): 69-71. 3、Lu, Hongzhou, Charles W. Stratton, and Yi - Wei Tang. Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle. J Med Virol.2020 Apr;92(4):401-402. 4、Lu, Hongzhou, Jingwen Ai, Yinzhong Shen, Yang Li, Tao Li, Xian Zhou, Haocheng Zhang et al. A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention. medRxiv (2020). 5、Lu, Hongzhou, Charles W. Stratton, and Yi - Wei Tang. The Wuhan SARS - CoV - 2- What's Next for China. J Med Virol, 2020. 6、Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect.2020Jan 1;9(1):687-90. 7、Ling, Yun, Shui-Bao Xu, Yi-Xiao Lin, Di Tian, Zhao-Qin Zhu, Fa-Hui Dai, Fan Wu, Lu, Hongzhou. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 2020 May 5;133(9): 1039-1043. 8、Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, Xiong W, Yang D, Chen R, Lu F, Lu Y. Zhou Min, Lu H, Qu J. COVID-19 with Different Severity: A Multi-center Study of Clinical Features. Am J Respir Crit Care Med.2020 Apr 10. 9、Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, Li F, Xu Q, Zhang Y, Xu S, Song Z, Zeng Y, Shen Y, Shi Y, Zhu T, Lu H. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020 May; 80(5): el-e6. 10、陈军，刘丹萍，刘莉，刘萍，徐庆年，夏露，凌云，黄丹，宋树丽涨丹丹,钱志平，李涛，沈银忠, 卢洪洲.硫酸羟氯喳治疗普通型2019冠状病毒病(COVID-19)患者初步研究.浙江 大学学报(医学版)2020,49(1):0-0. 11、沈银忠，卢洪洲.提高对新型冠状病毒感染诊治的认识，中华传染病杂志.2020 2019 年 12、Qi Tang, Min Liu, Hongzhou Lu Prevention of mother-to-child transmission (PMTCT) continues to play a vital role in the response to HIV/AIDS: Current status and future perspectives BioScience Trends 2019 Mar 14;13(l):107-l09. 13、Fengdi Zhang, Junyang Yang, Yongjia Ji, Meiyan Sun, Jiayin Shen, Jianjun Sun, Jiangrong Wang, Li Liu, Yinzhong Shen, Renfang Zhang, Jun Chen, Hongzhou Lu Gut Microbiota Dysbiosis Is Not Independently Associated With Neurocognitive Impairment in People Living With HIV Frontiers in Microbiology 2019 Jan 28;9:3352. 14、Junyang Yang, Jun Chen, Yongjia Ji, Qi Tang, Renfang Zhang, Li Liu, Yinzhong Shen, Jingna Xun, Wei Song, Yang Tang, Zhenyan Wang, Tangkai Qi, Hongzhou Lu Lipid profile and renal safety of tenofovir disoproxil fumarate-based anti-retroviral therapy in HIV-infected Chinese patients INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 2019 Jun;83:64-71. 15、Zhenyan Wang,Min Zhang,Renfang Zhang,Li Liu,Yinzhong Shen,Jiangrong Wang,Hongzhou Lu Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China BMC INFECTIOUS DISEASES 2019 Apr 8;19(1):313. 16、Hongzhou Lu, Yi-Wei Tang Myths in the laboratory diagnosis of HIV infection Emerging Microbes &Infections 2019;8(1):1240-1242 17、Qi Tang Hongzhou Lu The epidemic of major sexually transmitted diseases in Shanghai, China, 2009-2018 Bioscience Trends 2019;13(3):273-275. 18、Qi Tang Hongzhou Lu Immediate antiviral therapy for HIV-infected persons faces with various obstacles Drug Discoveries &Therapeutics 2019 Jul 22;13(3): 172-174. 19、Jun Chen Jingna Xun,Junyang Yang,Yongjia Ji,Li Liu,Tangkai Qi,Zhenyan Wang,Renfang Zhang,Yinzhong Shen,Rosalie Ponte,Vikram Mehrey,Jean-Pierre Routy Hongzhou Lu Plasma Indoleamine 2,3-Dioxygenase Activity Is Associated With the Size of the Human Immunodeficiency Virus Reservoir in Patients Receiving Antiretroviral Therapy CLINICAL INFECTIOUS DISEASES 2019;68(8):1274-1281. 20、Jun Chen ,Renfang Zhang,Yinzhong Shen,Li Liu,Qi Tang,Zhenyan WangVikram Mehraj,Routy JP Hongzhou Lu Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis HIV MEDICINE 2019 Jan;20(l):69-73. 21、Hong Xiao,Jun Chen Jiangrong Wangjuhua Li,Feia Yang, Hongzhou Lu Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection MEDICINE 2019 JuI;98(30):el6524. 22、Wei-Ti Chen, Chengshi Shiu,Joyce P. Yang,Myo Mie Mie Tun,Lin Zhang,Kerong Wang,Li-Chen Chen,Myo Nyein Aung, Hongzhou Lu, Hongxin Zhao Tobacco use and HIV symptom severity in Chinese people living with HIV AIDS Care 2019 May 22:1-6. 23、Yinzhong Shen,Chih-Ming Ho,Xianting Ding, Tingyi Liu,Jun Chen,Xin Li,Li Liu,Jiayin Shen,Jiangrong Wang,Renfang Zhang,Meiyan Sun,Zhenyan Wang,Wei Song,Tangkai Qi,Yang Tang,Xianmin Meng,Lijun Zhang,Dean Ho,Chih-Ming Ho,Xianting Ding Harnessing artificial intelligence to optimize long-term maintenance dosing for antiretroviral-naive adults with HIV-1 infection Advanced Therapeutics 2019,1900114 24、Jun Chen、Hongzhou Lu*,Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis, 2018 Oct 23;8(1):15617. 25、Junyang Yang,QiTang,Tangkai Qi(共一),Hongzhou Lu*,Characteristics and Outcomes of Acinetobacter baumannii Infections in Patients with HIV: A Matched Case-Control Study, 2018 Oct 23;8(1):15617. 26、Wenqi Chu, YixiongZhou (共一)：Hongzhou Lu*^ Jiayin Shen*, Bi-specific ligand-controlled chimeric antigen receptor T-cell therapy for non-small cell lung cancer , 2018 Jul 17; 12(3):298-308. 27、Jun Chen> Hongzhou Lu*Plasma indoleamine 2,3-dioxygenase activity is associated with the size of HIV reservoir in patients receiving antiretroviral therapy, Clin Infect Dis. 2018 Aug 10. 28、Yongjia Ji, Fengdi Zhang(共一)、Jun Chen*,Hongzhou Lu*Changes in intestinal microbiota in HIV-1- infected subjects following cART initiation: influence of CD4+ T cell count, 2018;7(l):l 13. 29、Yan Yan ,Yong Re (共一)Hongzhou Lu*,Lihua Huang*Evaluation of Epstein-Barr Virus Salivary Shedding in HIV/AIDS Patients and HAART Use: A Retrospective Cohort Study , 2018 Jun;33(3):227-233. 30、Yongjia Ji Pei-Pei Liang, Jia-Yin Shen (共—)、Hongzhou Lu*,Risk factors affecting the mortality of HIV-infected patients with pulmonary tuberculosis in the cART era A retrospective cohort study in China , 2018 Mar 24;7( 1):25 31、Zhenyan Wang、Hongzhou Lu*,The clinical and laboratory features of neurosyphilis in HIV-infected patients: A retrospective study in 92 patients , 2018Mar;97(9):e0078. 32、Wei-Ti Chen、Hongxin Zhao *, Hongzhou Lu*,Substance use, anxiety, and self¬management efficacy in HIV-positive individuals: A mediation analysis , 22 Feb 2018.Volume 23,2018 - Issue 4 408-414 33、Li Liu> Hongzhou Lu*,The importance of non-tuberculous mycobacteria identification inChinese patients infected with HIV, 2018; 12(5):515-516. 34、Qi Tang、Hongzhou Lu*,HIV/AIDS responses in China should fbcus on the impact of global integration, 2018; 12(5):507-509